- TheStreet.com•7 hours ago
The pharmaceutical company's new strategy emphasizes new product launches and international expansion.
- Reuters•13 hours ago
The following are the top stories in the Wall Street Journal. Reuters has not verified these stories and does not vouch for their accuracy. - President Barack Obama shortened Chelsea Manning's 35-year ...
- Reuters•20 hours ago
A unit of Botox maker Allergan Plc will pay a $15 million penalty and admit to wrongdoing, after U.S. regulators on Tuesday accused the unit of failing to disclose 2014 merger talks with Actavis, the U.S. Securities and Exchange Commission said. In a statement on Tuesday, the SEC said that the disclosure failures occurred in the months after the company received a tender offer from Valeant Pharmaceuticals International and co-bidder Pershing Square Capital Management, the hedge fund run by Bill Ackman.
AGN : Summary for Allergan plc Ordinary Shares - Yahoo Finance
Allergan plc (AGN)
NYSE - NYSE Real Time Price. Currency in USD
Add to watchlist
|Day's Range||214.70 - 218.99|
|52 Week Range||184.50 - 301.98|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||6.08|
|Dividend & Yield||2.80 (1.30%)|
|1y Target Est||N/A|